CEO Podcast: Hengrui's US Subsidiary's CEO, CMO On Chinese Pharma Going Global
Luzsana Execs Talk On Challenges And Opportunities
While many pharma firms in China choose to partner with US companies, Jiangsu Hengrui is relying on itself to go global. The Chinese pharma giant is betting on its newly established US subsidiary Luzsana in a major move to make its wide-ranging products more available, accessible and affordable to patients in the US and the rest of the world.
